"...a convicted felon. "
A lot of folks on that forum
"...a convicted felon. "
A lot of folks on that forum are unaware that the guy who actually founded the IH site years ago got busted for stock manipulation using the site he built for the purpose of stock manipulation fraud. I don't remember his name but this is a true historical fact. And it is really not all that surprising given how far crooks will go to steal our money over the Internet
As far as the negative contingent of bashers who post there now on the DECN forum, I have most (or all) of them on Ignore. ADVFN used to allow only 10 ignores for non-paying subscribers. But apparently they removed that arbitrary limit because I have 20+ on Ignore now. And I am ready and waiting for more to show up. I highly recommend the Ignore feature.
I just checked the IH DECN forum a moment ago and it showed 28 unread posts in my queue. But when I went to read them there were only 3 posts to read. The other 25 posts are all from Ignores. Now why in the world would I want to spend any of my time reading negative posts? It makes absolutely no sense to me at all. And it really pisses me off to read their continuous lies and distortions of the facts. So I don't have to, thanks to the Ignore feature.
At 76 years old, I am not a naive investor or a beginner. I have been investing in penny stocks since the early 1970's, long before there was online trading. I purchased my first DECN shares on May 14, 2013, 3000 @ 23 cents. On Nov 11, 2013 it hit $1.08 a share. I did a quick sanity check to decide if I should take profits. I believed then as I do now that there is more upside to come and that this is a very worthwhile investment, so I held. Then a while later DECN got sued by Johnson & Johnson in a totally fraudulent patent infringement suit. There was NO valid patent, and J&J ran in a so called "expert witness" who turned out to be a total fraud and a liar. DECN prevailed in that suit but it set the company back 4 years. OUCH!
Through all of the setbacks and turmoil over the years Mr Berman has stayed the course and kept this company moving forward. When you invest in a penny stock there is always big risk. You don't invest in a product or process as much as you are investing in the People and their Vision.
As far as I am concerned, "the handwriting is on the wall" so to speak. I do believe that Mr Berman is going to make me a whole lot of money. My exit price is $15/share and hopefully I will get that in the spring of 2022. The trend is set.
I just thought I would share all of this because I have been around a very long time, and I don't post much. I started out on RagingBull years ago and then moved on to Yahoo, then IH, and now I am here. I used to moderate 23 forums on IH because no one else wanted the job. But I got kicked off by the fraudsters when I deleted their posts for rules violation. That was my job and responsibility and I got punished for it.
So Good Luck to All Longs, God Bless You and Your Family, wear a mask and keep your distance.
N2N
6
Decision Diagnostics Corp (DECN) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
AI's Growing Pains in the Legal Arena Looks like the legal eagles are getting a run for their money with AI entering the courtroom. Bloomberg Law's 2026 AI in Practice report dives deep into this legal labyrinth. You got attorneys leaning on AI to keep the gears turning, but they're also clutching their pearls over potential pitfalls. Trust Issues: Humans vs. Machines The...
Continue Reading
Siemens Seizing New Opportunities with Lauterbach Acquisition Bam! Siemens is on the move, folks, snapping up Lauterbach to bolster its semiconductor design arsenal. Now, if you’ve got your eyes glued to innovation in chip design, like yours truly, then strap in because this merger is more than just a footnote on some dusty tech page. It's a game-changer when it comes...
Continue Reading
Jinko Solar's Invitation to the B20 Summit Never a dull moment in the solar space, especially when Jinko Solar, a big shot in clean energy, jumps into the spotlight at the B20 Summit in the U.S. Awash with high-profile discussions, Jinko's not just chatting—it's the only photovoltaic firm strutting its stuff in D.C. with gutsy calls for energy reform. Key Takeaways from...
Continue Reading
Cracking the Diabetes Code: A New Hope Emerging It ain't every day you hear about a biotech outfit snagging an NIH Fast-Track grant with the potential to upend diabetes treatment, but Paulex Bio's recent score turns heads. Their brainchild, PAL-119, promises to tackle diabetes not by slapping a band-aid on symptoms, but by getting to the rotten core of the disease: the...
Continue Reading
Shifting the Healthcare Paradigm Imagine a healthcare world where doctors actually have the time to listen and engage with you beyond just scribbling notes in haste. That's what's brewing over in Westchester, where Dr. Rachana and Dr. Vaishalee Shukla are putting the old-school patient-doctor relationship front and center with their Hybrid Choice concierge program. Run...
Continue Reading
Taking Aim at a Deadly Habit Everyone's got that gut feeling when a day-long meeting runs over or you're stuck in traffic — impatience morphed with slow burn menace. Now picture a whole campaign gunning for that vibe but in the hands of the young folks, those from 21 to 34. That's what we're talking about here, with the Ad Council and NHTSA serving up some fresh public...
Continue Reading
Moving AI from Theory to Practice You know, AI isn't about just keeping up with the hype; it's about shoving those algorithms right where they can do the most good—right at the core of business operations. And that’s precisely what Cognizant's cooking up with their fresh-off-the-press Claude Frontier Capability Group. They’ve thrown more than 25,000 pros into the...
Continue Reading
Bandwidth Unleashes Super Intelligence at Reverb Right off the bat, Bandwidth's Reverb showcase was enough to stir up some excitement in the air. The company laid out a feast of technological advancements with their Super Intelligence (SI) innovations that claim to redefine how enterprises communicate. But here's the rub—while these developments sound thrilling, the...
Continue Reading
The Road to Digital Unity in HME Cranking through the gears of the healthcare industry is no mean feat, but Parachute Health seems ready to throw some fresh oil on the machine. In a landscape riddled with complexities, they're sounding the call for a more unified digital infrastructure in the Home Medical Equipment (HME) sector through their latest white paper. We're...
Continue Reading
Upcoming Unveiling: Pearl Diver's Latest Financials Heads up, folks. November 16 can't come soon enough for those keeping tabs on Pearl Diver Credit Company Inc. (NYSE: PDCC, PDPA). The bigwigs over there are planning to spill the beans on their third quarter 2026 financial results. They'll kick things off before the market even has its first cup of java on Monday morning...
Continue Reading
Top 5 Most Recently Viewed Articles
Boardwalktech Software Demonstrates Commitment to Innovation Boardwalktech Software Corp. (TSXV: BWLK) (OTCQB: BWLKF), recognized as a leader in the Intelligent Information Platform sector, has announced that their CEO and Chairman, Andrew Duncan, is set to present at the highly anticipated Planet MicroCap Showcase. This event, in partnership with MicroCapClub, serves as...
Continue Reading
Sabio Holdings' Creator Television® Triumphs at Industry Awards In an impressive early success, Creator Television®, a project of Sabio Holdings, has clinched the 'Most Significant Newcomer' award at the InteractiveTV Today (ITVT) Awards. This recognition comes as a significant milestone for the company during Creator TV's first six months since launch. An Award for...
Continue Reading
Starbucks Corporation Faces Investigation In recent developments, Kahn Swick & Foti, LLC has started an investigation regarding Starbucks Corporation (NASDAQ: SBUX). Led by former Louisiana Attorney General Charles C. Foti, Jr., this inquiry raises important questions about the company and its executives. Financial Performance Raises Red Flags Starbucks' recent financial...
Continue Reading
Exploring the Efficacy of LV UNO Therapy in Cancer Treatment Beyond Cancer, Ltd. has introduced groundbreaking preclinical data showcasing the benefits of Low Volume Ultra-High Concentration Nitric Oxide (LV UNO) therapy. This therapy, when combined with immune checkpoint inhibitors, demonstrates significant potential for enhancing patient outcomes in cancer treatments....
Continue Reading
Wabash and Decisiv Forge a New Partnership Wabash, a leading provider of innovative supply chain solutions, has formed a strategic partnership with Decisiv to enhance service management capabilities within its dealer network. This collaboration aims to streamline service event management and improve uptime for Wabash customers. Decisiv's Impact on Service Management The...
Continue Reading